Beta Drugs Ltd.

•

betadrugslimited.comBSE: -NSE: BETA

Market Cap₹ 2,356 Cr.

Current Price

High / Low₹ 2,808 / 990

Stock P/E56.8

Book Value₹ 236

Price to Book9.76

Dividend Yield0.00 %

ROCE25.2 %

ROE24.0 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 35.1% CAGR over last 5 years
Company has a healthy return on capital (ROCE) of 30.6%
Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%
Latest quarter profit grew 1724.9% YoY, showing strong momentum
Company has delivered good sales growth of 31.9% CAGR over last 5 years
Company has consistently been profitable over the last 5 years

CONS

Promoter holding has decreased over last 2 years: -7.6pp
Total debt has risen sharply - up 838.5% year on year
Working capital days have increased from 115 to 230 days
Stock is trading at 9.8x its book value
Operating margins have contracted to 20.6% from 23.6%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BETA	2118.50	56.80	2356.04	0.00	164.86	1724.88	1255.50	1239.00	25.23	21.80

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026	Jun 2026
	88	94	100	87	94	126
	70	76	88	70	76	105
Operating Profit	18	17	13	17	18	20
OPM %	20.90%	18.49%	12.63%	19.47%	18.81%	16.30%
	-1	2	3	2	3	2
Interest	2	3	3	4	4	3
Depreciation	3	4	4	4	5	4
Profit before Tax	12	12	16	10	12	22
Tax %	25.17%	26.17%	25.23%	18.72%	23.50%	25.21%
Net Profit	0	0	12	9	9	16
	9.31	9.40	11.59	8.40	8.93	14.78

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	51	66	91	116	184	227	296	362	407
	41	54	73	91	141	174	236	288	339
Operating Profit	9	12	18	25	43	53	60	75	68
OPM %	18.70%	17.91%	19.72%	21.31%	23.23%	23.39%	20.29%	20.59%	16.66%
	0	0	0	1	1	1	1	2	10
Interest	1	1	3	2	2	2	3	7	14
Depreciation	2	3	4	7	7	10	10	13	17
Profit before Tax	7	8	12	16	34	41	49	57	60
Tax %	1.05%	-1.69%	21.36%	26.50%	27.62%	25.18%	25.26%	25.54%	23.74%
Net Profit	7	8	9	12	25	31	36	42	46
EPS	0.00	0.00	0.00	12.20	25.82	31.95	37.90	42.02	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 32%
3 Years:: 25%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 35%
3 Years:: 20%

STOCK PRICE CAGR

10 Years:: —
5 Years:: 43%
3 Years:: 31%
1 Year:: 14%

RETURN ON EQUITY

10 Years:: —
5 Years:: 26%
3 Years:: 26%
Last Year:: 24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9	9	10	10	10	10	10	10
	24	32	47	59	83	113	148	187
	9	23	26	22	24	24	20	140
Trade Payables	6	13	14	20	32	40	59	71
	2	7	11	9	15	17	26	37
Total Liabilities	50	83	108	120	163	204	262	445
	13	18	44	40	55	63	65	89
Capital Work in Progress	1	15	0	3	0	0	0	0
	0	0	0	1	1	1	0	0
	3	10	12	16	22	31	50	60
	0	0	0	0	0	0	79	103
Cash & Bank	12	3	5	10	17	19	29	147
	20	38	46	50	68	91	40	47
Total Assets	50	83	108	120	163	204	262	445

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	17	0	8	19	30	23	31	36
Cash from Investing	-11	-21	-15	-6	-22	-19	-14	-36
Cash from Financing	5	12	9	-8	-1	-2	-7	118
	12	-9	2	5	7	2	9	118

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66.73	66.73	66.73	66.73	66.73	66.73	64.90	64.63	59.10
	0.90	1.15	1.15	0.90	0.90	0.90	1.14	1.16	1.02
	0.10	0.15	0.15	0.15	0.24	0.28	1.88	2.14	6.22
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.27	31.96	31.96	32.21	32.12	32.08	32.08	32.07	33.66

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - Beta Drugs Limited has informed the Exchange about Schedule of meet

2026-09-07

Copy of Newspaper Publication

2026-09-07 - Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-05

Shareholders meeting

2026-09-05 - Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-03

General Updates

2026-09-03 - Beta Drugs Limited has informed the Exchange about 'Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2026 to 30-Sep-2026 for the purpose of ANNUAL GENERAL MEETING to be held on 30.09.2026

2026-09-03

Shareholders meeting

2026-09-03 - Beta Drugs Limited has informed the Exchange regarding Notice of undefined to be held on September 30, 2026

2026-09-03

Outcome of Board Meeting

2026-09-03 - Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

2026-08-18

Outcome of Board Meeting

2026-08-18 - Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026.

2026-08-14

Monitoring Agency Report

2026-08-14 - Monitoring Agency Report for the Quarter ended 30th June, 2026

2026-07-27

Investor Presentation

2026-07-27 - Beta Drugs Limited has informed the Exchange about Investor Presentation

News

Recent coverage and analyst commentary for BETA

Loading news…

🤖

AI Stock Analyst

Beta Drugs Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

BETA

2118.50

56.80

2356.04

0.00

164.86

1724.88

1255.50

1239.00

25.23

21.80

Dec 2024

Mar 2025

Jun 2025

Dec 2025

Mar 2026

Jun 2026

100

126

105

Operating Profit

OPM %

20.90%

18.49%

12.63%

19.47%

18.81%

16.30%

-1

Interest

Depreciation

Profit before Tax

Tax %

25.17%

26.17%

25.23%

18.72%

23.50%

25.21%

Net Profit

9.31

9.40

11.59

8.40

8.93

14.78

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

116

184

227

296

362

407

141

174

236

288

339

Operating Profit

OPM %

18.70%

17.91%

19.72%

21.31%

23.23%

23.39%

20.29%

20.59%

16.66%

Interest

Depreciation

Profit before Tax

Tax %

1.05%

-1.69%

21.36%

26.50%

27.62%

25.18%

25.26%

25.54%

23.74%

Net Profit

EPS

0.00

12.20

25.82

31.95

37.90

42.02

—

Dividend Payout %

0.00%

—

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

113

148

187

140

Trade Payables

Total Liabilities

108

120

163

204

262

445

Capital Work in Progress

103

Cash & Bank

147

Total Assets

108

120

163

204

262

445

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Cash from Investing

-11

-21

-15

-6

-22

-19

-14

-36

Cash from Financing

-8

-1

-2

-7

118

-9

118

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

66.73

64.90

64.63

59.10

0.90

1.15

0.90

1.14

1.16

1.02

0.10

0.15

0.24

0.28

1.88

2.14

6.22

Government

0.00

32.27

31.96

32.21

32.12

32.08

32.07

33.66

Beta Drugs Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Beta Drugs Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI